Community Research and Development Information Service - CORDIS


Biomaterials for healthcare: A decade of EU-funded research, EUR 22817

Funded under: FP5, FP6


Biomaterials are materials with novel properties that make them especially suitable to have an intimate contact with living tissue, and are produced through processes that often employ or mimic biological phenomena.
Biomaterials are revolutionising many aspects of preventive and therapeutic healthcare. They are already playing an important role in the development of new medical devices, prostheses, tissue repair and replacement technologies, drug delivery systems and diagnostic techniques.
With huge potential quality-of-life benefits for all, biomaterials are the focus of major research efforts around the world. Progress in this field requires a multidisciplinary approach, where scientists (chemists, physicists, mathematicians, biologists and medical doctors), interact with engineers, materials producers and manufacturers.
Moreover, the nature of the challenges is such that finding solutions often demands an investment of skills and resources that are beyond the capabilities of a single organisation, or even of a single country.
Collaborative research is thus the key to achieving breakthrough results likely to bring leadership in the global marketplace.
The European Union (EU) has funded biomaterials research projects (RTD) under its Fifth and Sixth Framework Programmes for almost a decade. The following pages trace the progress of this work, illustrated by examples of projects that have achieved significant advances or highlighted fruitful areas for continuing investigation.

Download application/pdf (788628)

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top